The rating affirmation was based on a number of factors, including Blanchard’s dominant market position and manageable capital needs over the next several years.
Offsetting these strengths are the system’s moderate size, which contributes to variable volume intake and a declining but relatively high debt position.
The outlook is stable, which reflects Moody’s expectation that operating margins will stay strong, no new material debt will be issued and the investment position will remain strong given capital plans.
More articles on finance:
Skyrocketing chemo costs push fresh look at cancer care management
CMS delays release of risk corridor program results
9 latest CFO moves in hospitals, health systems
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
